1. Home
  2. OPRX vs NMAI Comparison

OPRX vs NMAI Comparison

Compare OPRX & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

HOLD

Current Price

$14.31

Market Cap

272.0M

ML Signal

HOLD

Logo Nuveen Multi-Asset Income Fund of Beneficial Interest

NMAI

Nuveen Multi-Asset Income Fund of Beneficial Interest

HOLD

Current Price

$13.32

Market Cap

429.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRX
NMAI
Founded
2006
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Investment Managers
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
272.0M
429.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OPRX
NMAI
Price
$14.31
$13.32
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$14.83
N/A
AVG Volume (30 Days)
275.5K
74.8K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
13.14%
EPS Growth
N/A
N/A
EPS
0.00
0.64
Revenue
$109,506,000.00
N/A
Revenue This Year
$19.77
N/A
Revenue Next Year
$11.33
N/A
P/E Ratio
$7,807.14
$19.03
Revenue Growth
24.18
N/A
52 Week Low
$3.99
$10.60
52 Week High
$22.25
$12.55

Technical Indicators

Market Signals
Indicator
OPRX
NMAI
Relative Strength Index (RSI) 38.43 61.72
Support Level $13.95 $13.14
Resistance Level $16.37 $13.37
Average True Range (ATR) 0.72 0.16
MACD 0.06 0.04
Stochastic Oscillator 33.66 92.65

Price Performance

Historical Comparison
OPRX
NMAI

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest

Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.

Share on Social Networks: